Utz Krug, MD, from the Leverkusen Clinic, Leverkusen, Germany, discusses whether 7+3 as induction therapy for acute myeloid leukemia (AML) can be optimized at the International Symposium on Acute Leukemias (ISAL) 2017 in Munich, Germany. [More]
This video describes the schedule and treatment with Taxol/Erbitux chemotherapy for head and neck cancer. You should first watch the general information chemotherapy video on the charlottecancer channel before viewing this.
This presentation provides information to assist clinicians in identifying patients with Acute Myeloid Leukemia and selecting appropriate treatment options based on clinical and genetic variables. The presentation also reviews appropriate criteria for investigational/novel therapies and [More]